help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blaustein, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blaustein, J. D.

Endocrinology, Vol 132, 1218-1224, Copyright © 1993 by Endocrine Society


ARTICLES

Estrogen receptor immunoreactivity in rat brain: rapid effects of estradiol injection

JD Blaustein
Neuroscience and Behavior Program, University of Massachusetts, Amherst 01003.

The existence of cytoplasmic estrogen receptor immunoreactivity (ER-IR) has been reported in the brain using three different antibodies raised against different epitopes on the ER protein. With each antibody, the darkest reaction product was seen within cell nuclei, but cytoplasmic ER-IR was also observed with each antibody in most neuroanatomical areas. We have reported previously that an injection of estradiol causes a rapid decrease in ER-IR in ovariectomized guinea pigs when the H 222 estrogen receptor antibody was used. In extending this work to rats, we used three different ER antibodies to determine if this decrease in ER-IR is likely to be due to down-regulation of the receptor by estradiol or a decrease in the ability of some antibodies to bind to their particular epitopes on the receptor. Estradiol injection in ovariectomized rats caused a rapid (within 20 min), nearly total loss of cytoplasmic ER-IR when the H 222 antibody was used to visualize the receptor. This decrease did not appear to be due to movement of the receptors to the cell nucleus, as cell nuclear ER-IR also decreased. When other antibodies were used, the extent of loss and the pattern of immunostaining were greatly influenced by the particular antibody. Extensive loss of cytoplasmic and cell nuclear ER-IR was seen when an antiserum against the hinge region of the receptor was used. However, when an antiserum against the N-terminus of the ER was used, a decrease was seen in cytoplasmic ER-IR, but little or no decrease was observed in cell nuclear ER-IR. Because loss of cell nuclear ER-IR was not seen with all of the antibodies, these results suggest that the dramatic decrease in cell nuclear ER-IR seen immediately after estradiol injection is due at least in part to a conformational change in the receptor. This, in turn, may impede association with particular antibodies during the immunocytochemical procedure.


This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
L. W. Baum
Sex, Hormones, and Alzheimer's Disease
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(6): 736 - 743.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. M. Davis, M. L. Seney, H. J. Walker, and S. A. Tobet
Differential Colocalization of Islet-1 and Estrogen Receptor {alpha} in the Murine Preoptic Area and Hypothalamus during Development
Endocrinology, January 1, 2004; 145(1): 360 - 366.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. D. Foradori, L. M. Coolen, M. E. Fitzgerald, D. C. Skinner, R. L. Goodman, and M. N. Lehman
Colocalization of Progesterone Receptors in Parvicellular Dynorphin Neurons of the Ovine Preoptic Area and Hypothalamus
Endocrinology, November 1, 2002; 143(11): 4366 - 4374.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. S. Cotroneo, J. Wang, W. A. Fritz, I.-E. Eltoum, and C. A. Lamartiniere
Genistein action in the prepubertal mammary gland in a chemoprevention model
Carcinogenesis, September 1, 2002; 23(9): 1467 - 1474.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Greco, E. A. Allegretto, M. J. Tetel, and J. D. Blaustein
Coexpression of ER{beta} with ER{alpha} and Progestin Receptor Proteins in the Female Rat Forebrain: Effects of Estradiol Treatment
Endocrinology, December 1, 2001; 142(12): 5172 - 5181.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Nadal, A. B. Ropero, O. Laribi, M. Maillet, E. Fuentes, and B. Soria
Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta
PNAS, October 10, 2000; 97(21): 11603 - 11608.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. A. Ishunina, F. P. M. Kruijver, R. Balesar, and D. F. Swaab
Differential Expression of Estrogen Receptor {alpha} and {beta} Immunoreactivity in the Human Supraoptic Nucleus in Relation to Sex and Aging
J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3283 - 3291.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
J. R. Wood, G. L. Greene, and A. M. Nardulli
Estrogen Response Elements Function as Allosteric Modulators of Estrogen Receptor Conformation
Mol. Cell. Biol., April 1, 1998; 18(4): 1927 - 1934.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. N. Roemmich, X. Li, A. D. Rogol, and E. F. Rissman
Food Availability Affects Neural Estrogen Receptor Immunoreactivity in Prepubertal Mice
Endocrinology, December 1, 1997; 138(12): 5366 - 5373.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society